Sign in

CIK 0001826457 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
  1. 8-K Event Executive or director change · Regulation FD disclosure
  2. 144 Insider Sale of Securities
  3. ARS Other Annual Report to Security Holders
  4. DEFA14A Proxy Proxy Materials
  5. DEF 14A Proxy Proxy Statement
  6. 144 Insider Sale of Securities
  7. SC 13G/A Stake Amended Statement of Ownership
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. 10-K Report Annual Report
  10. 8-K Event Results of operations · Regulation FD disclosure
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 8-K Event Regulation FD disclosure
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 11 of 21 · 401 filings